JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $631

Elevance Health, Inc. Common Stock +4.24% Pre

Elevance Health, Inc. Common Stock

ELV

553.14

553.14

+4.24%

0.00% Pre

JP Morgan analyst Lisa Gill maintains Elevance Health (NYSE: ELV) with a Overweight and raises the price target from $628 to $631.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via